M&A Deal Summary

Dendrite International Acquires Optas

On September 12, 2005, Dendrite International acquired marketing company Optas for 12M USD

Acquisition Highlights
  • This is Dendrite International’s 1st transaction in the Marketing sector.
  • This is Dendrite International’s largest (disclosed) transaction.
  • This is Dendrite International’s 1st transaction in the United States.
  • This is Dendrite International’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2005-09-12
Target Optas
Sector Marketing
Buyer(s) Dendrite International
Deal Type Add-on Acquisition
Deal Value 12M USD

Target

Optas

Woburn, Massachusetts, United States
Optas is a relationship marketing firm.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Dendrite International

Bedminster, New Jersey, United States
Category Company
Founded 1987
Sector Information Technology
Employees2,524
DESCRIPTION

Dendrite International enables sales, marketing, clinical and compliance solutions for the global pharmaceutical industry. The Company’s clients are located in more than 50 countries and include the world's top 20 pharmaceutical companies.

DEAL STATS #
Overall 1 of 2
Sector (Marketing) 1 of 1
Type (Add-on Acquisition) 1 of 2
State (Massachusetts) 1 of 1
Country (United States) 1 of 2
Year (2005) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-09-05 Opus Health

Hauppauge, New York, United States

Opus Health LLC was a provider of direct-to-patient persistence technologies to the pharmaceutical industry.

Buy -
Mergr

Product

Company

Legal